Clinical Trials for Acquired Pure Red Cell Aplasia

Find clinical trials for acquired pure red cell aplasia. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

NCT ID: NCT06412497

This clinical trial, titled MT2023-20, is exploring a new treatment approach for patients with severe aplastic anemia and other related conditions that affect the bone marrow, such as paroxysmal no...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Linperlisib in the Treatment of aPRCA

NCT ID: NCT07031115

This clinical trial is studying a medicine called Linperlisib to treat a rare blood condition called acquired pure red cell aplasia (aPRCA). In aPRCA, the body stops making enough red blood cells, ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions